With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.28 million shares. During the session, the Pharmaceutical Retailers company that operates in wider Healthcare sector, reached to the highest price of $5.34 whereas the lowest price it dropped to was $4.94. The 52-week range on PETS shows that it touched its highest point at $7.79 and its lowest point at $2.90 during that stretch. It currently has a 1-year price target of $3.75. PETS paid its most recent dividend on 1691712000, while the ex-dividend date for that was 1691712000. Beta for the stock currently stands at 0.67.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PETS was down-trending over the past week, with a drop of -9.80%, but this was up by 8.52% over a month. Three-month performance surged to 42.41% while six-month performance rose 16.53%. The stock lost -32.20% in the past year, while it has lost -34.26% so far this year. A look at the trailing 12-month EPS for PETS yields -0.05 with Next year EPS estimates of -0.07. For the next quarter, that number is 0.01. This implies an EPS growth rate of 167.57% for this year and -126.00% for next year.
Float and Shares Shorts:
At present, 20.66 million PETS shares are outstanding with a float of 17.77 million shares on hand for trading. On 2024-11-29, short shares totaled 1.17 million, which was 567.99997 higher than short shares on 1730332800. In addition to Ms. Sandra Y. Campos as the firm’s President, CEO & Director, Ms. Christine Chambers serves as its Treasurer & Secretary.
Institutional Ownership:
Through their ownership of 0.47794998 of PETS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, PETS reported revenue of $59570000.0 and operating income of $554000.0. The EBITDA in the recently reported quarter was $2212000.0 and diluted EPS was $0.11.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PETS since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PETS analysts setting a high price target of 4.0 and a low target of 3.5, the average target price over the next 12 months is 3.75. Based on these targets, PETS could drop -19.52% to reach the target high and fall by -29.58% to reach the target low. Reaching the average price target will result in a decline of -24.55% from current levels.
Analysts have provided yearly estimates in a range of -$0.18865 being high and -$0.19135 being low. For PETS, this leads to a yearly average estimate of -$0.19. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
